Group 1: Elanco Animal Health - Jim Cramer recommended buying Elanco Animal Health Incorporated, praising the company's turnaround efforts [1] - Barclays analyst Glen Santangelo initiated coverage on Elanco with an Overweight rating and a price target of $30 [1] Group 2: Rocket Lab Corporation - Cramer described Rocket Lab as a "very good spec" ahead of a significant offering in the rocket industry next year [2] - Rocket Lab announced that its next Electron rocket launch has been moved forward, highlighting its role in responsive space operations for government customers [3] - The upcoming Electron launch will carry the STP-S30 mission for the U.S. Space Force's Space Systems Command [3] Group 3: Lithium Americas Corp. - Cramer recommended selling Lithium Americas Corp., labeling it a "yesteryear" stock [3] - Lithium Americas will join the S&P/TSX Composite index effective before the market opens on December 22 [3] Group 4: Daktronics, Inc. - Cramer described Daktronics as "just ok" and not compelling enough for investment [4] - Daktronics reported better-than-expected second-quarter financial results on December 10 [4] Group 5: M&T Bank Corporation - Cramer recommended buying M&T Bank Corporation, calling it a "very well-run" bank [4] - Analyst David Konrad maintained M&T Bank with a Market Perform rating and raised the price target from $220 to $230 [4] Group 6: Ondas Holdings Inc. - Cramer decided to pass on Ondas Holdings Inc. [5] - Ondas announced the completion of its acquisition of Roboteam Ltd. [5] Group 7: Price Action - Elanco shares fell 1.8% to settle at $22.08 [7] - Rocket Lab shares declined 2.8% to close at $53.96 [7] - Lithium Americas shares fell 3.6% to close at $4.61 [7] - Daktronics shares declined 0.9% to settle at $19.02 [7] - M&T Bank shares rose 1% to close at $206.12 [7] - Ondas Holdings shares dipped 6.1% to settle at $7.60 [7]